Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Nasal Spray Vaccine Shown to Control Peanut Allergies

A vaccine to protect against peanut allergies, given as a nanoscale droplets suspended in a nasal spray, is shown to prevent allergic reactions in tests with lab mice sensitized to peanuts. . . . → Read More: Nasal Spray Vaccine Shown to Control Peanut Allergies

Gene Therapy Biotech Acquired in $8.7 Billion Deal

A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal

Stem Cell Eye Implants Safe, Stop Visual Function Loss

Early results from a clinical trial show implants of replacement retina cells grown from stem cells are safe for people with a form of age-related macular degeneration, and at least stop the loss of visual function. . . . → Read More: Stem Cell Eye Implants Safe, Stop Visual Function Loss

Lilly, Cell Implants Start-Up Partner on Diabetes

Eli Lilly and Company is licensing a technology for implanting pancreatic beta cells in people with type 1 diabetes, from Sigilon Therapeutics Inc., an enterprise making implants of live cells to treat chronic diseases. . . . → Read More: Lilly, Cell Implants Start-Up Partner on Diabetes

New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells. . . . → Read More: New Company Acquires Off-the-Shelf T-Cell Cancer Therapies

Cough Suppressant Produced from Engineered Yeast Cells

A bioengineering group created a process for producing a cough suppressant in the lab, usually derived from opium poppies, but instead from genetically modified brewer’s yeast. . . . → Read More: Cough Suppressant Produced from Engineered Yeast Cells

Nanotech Pain Drug Formulations Developed

A pharmaceutical researcher developed treatments for chronic pain, formulated as nanoscale droplets, that in tests with lab animals target the source of pain directly and use much smaller doses than current pain drugs. . . . → Read More: Nanotech Pain Drug Formulations Developed

Antibodies Licensed for Multi-Target Immunotherapies

MedImmune, the biologics subsidiary of drug maker AstraZeneca, is licensing antibodies from a biotechnology company for treatments that simultaneously address two or more cancer targets. . . . → Read More: Antibodies Licensed for Multi-Target Immunotherapies

RNA Treatment Tested for West Nile Virus

A therapy for West Nile Virus made with interfering RNA molecules is shown in lab mice to reduce viral loads, including in the brain where the disease can do serious damage. . . . → Read More: RNA Treatment Tested for West Nile Virus

Drug Shown Able to Kill Malaria-Carrier Mosquitoes

A clinical trial in Kenya shows blood from people who take a current anti-parasite drug can kill mosquitoes carrying malaria, offering a potential new strategy for controlling this disease. . . . → Read More: Drug Shown Able to Kill Malaria-Carrier Mosquitoes